“immunology” Archives

in
Entry Author Date Location
Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug 10/04/17 Boston
San Antonio Spends $200,000 to Get New Biotech Pelican Therapeutics 09/25/17 Texas
Celgene Broadens Forma Deal, Adding $195M More for Drug R&D 08/29/17 New York
Illumina Accelerator Sees ‘Huge Impact in Genomics’ in New Startups 07/26/17 San Francisco
Constellation Reboots With Eye On Immuno-Oncology, Hires New CEO 05/25/17 Boston
Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M 04/13/17 New York
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More 12/16/16 National
Bellicum, Molecular Templates Granted $32M for Immuno-Oncology Work 11/17/16 Texas
Early Stage San Antonio Drug Trial Firm START Opens Taiwan Outpost 05/20/16 Texas
CPRIT Marks Midpoint in Texas Agency’s 10-Year Cancer-Fighting Mandate 05/18/16 Texas
The Xconversation: Vaccine Developer Meets Energy Innovator, Part II 03/30/16 Seattle
The Xconversation: Vaccine Developer Meets Energy Innovator, Part I 03/29/16 Seattle
East Coast Biotech Roundup: Cancer Vaccines, Biogen, LabCentral & More 10/23/15 Boston
La Jolla Immunology Institute Agrees to Formal Ties with UCSD 07/29/15 San Diego
Foresite Capital Keeps Late-Stage Healthcare Focus With $450M Third Fund 07/29/15 San Francisco
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
Celgene to Acquire San Diego’s Receptos for $7.2B in Cash 07/14/15 San Diego
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug 03/02/15 New York
Rice Consortium Helped Spark Biotech Researchers’ Inner Entrepreneur 11/06/14 Texas
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
As Expected, Nurix Taps Into $25M for New Drug Discovery 05/22/14 San Francisco
In Pursuit of Hot Autoimmune Target, GSK and Academics Team Up 05/12/14 San Francisco
East Coast Biotech Roundup: Sarepta, Alkermes, Boston Biotech, & More 04/25/14 Boston
La Jolla Institute Extends 25-Year Partnership with Japanese Pharma 07/31/13 San Diego
XBiotech Takes Aim at Inflammation That Weakens Cancer Patients 05/17/13 Texas
End of the Road for Torrey Path as Founder Starts New Trail with Sequencethree 06/14/11 San Diego
Immune Design, Developer of New Vaccines, Adds Former Elan President as New CEO 04/27/11 Seattle
Adimab Inks Novartis Deal, GSK-Founded Tempero Pursues Hot Immunology Field, Metamark Gets $22M, & More Boston-Area Life Sciences News 07/16/10 Boston
Glaxo’s Tempero Pharma Advances on Hot Niche of Immunology 07/15/10 Boston
Nathan Myhrvold, Lee Hood Forge Longstanding Partnership at Nexus of IT and Biology 03/24/10 Seattle
Page 1 of 2 next page »